Unknown

Dataset Information

Bridging the gap: a review of dose investigations in paediatric investigation plans.


ABSTRACT:

Aims

In the EU, development of new medicines for children should follow a prospectively agreed paediatric investigation plan (PIP). Finding the right dose for children is crucial but challenging due to the variability of pharmacokinetics across age groups and the limited sample sizes available. We examined strategies adopted in PIPs to support paediatric dosing recommendations to identify common assumptions underlying dose investigations and the attempts planned to verify them in children.

Methods

We extracted data from 73 PIP opinions recently adopted by the Paediatric Committee of the European Medicines Agency. These opinions represented 79 medicinal development programmes and comprised a total of 97 dose investigation studies. We identified the design of these dose invest

SUBMITTER: Hampson LV 

PROVIDER: S-EPMC4239983 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature